Next Article in Journal
Chemical Composition and Anticholinesterase Activity of the Essential Oil of Leaves and Flowers from the Ecuadorian Plant Lepechinia paniculata (Kunth) Epling
Previous Article in Journal
The Latest Trends in Electric Vehicles Batteries
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling

1
Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong-gu, Busan 46241, Korea
2
Interdisciplinary Research Programme of Bioinformatics and Longevity Science, Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong-gu, Busan 46241, Korea
3
College of Pharmacy, Inje University, Gimhae 50834, Gyeongsangnam-do, Korea
4
Graduate School Science and Engineering for Research, University of Toyama, Toyama 930-8555, Japan
*
Authors to whom correspondence should be addressed.
Molecules 2021, 26(11), 3197; https://doi.org/10.3390/molecules26113197
Submission received: 13 April 2021 / Revised: 11 May 2021 / Accepted: 14 May 2021 / Published: 26 May 2021

Abstract

PPARα is a ligand-dependent transcription factor and its activation is known to play an important role in cell defense through anti-inflammatory and antioxidant effects. MHY3200 (2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2,2-difluoroacetic acid), a novel benzothiazole-derived peroxisome proliferator-activated receptor α (PPARα) agonist, is a synthesized PPARα activator. This study examined the beneficial effects of MHY3200 on age-associated alterations in reactive oxygen species (ROS)/Akt/forkhead box (FoxO) 1 signaling in rat kidneys. Young (7-month-old) and old (22-month-old) rats were treated with MHY3200 (1 mg/kg body weight/day or 3 mg/kg body weight/day) for two weeks. MHY3200 treatment led to a notable decrease in triglyceride and insulin levels in serum from old rats. The elevated kidney ROS level, serum insulin level, and Akt phosphorylation in old rats were reduced following MHY3200 treatment; moreover, FoxO1 phosphorylation increased. MHY3200 treatment led to the increased level of FoxO1 and its target gene, MnSOD. MHY3200 suppressed cyclooxygenase-2 expression by activating PPARα and inhibiting the activation of nuclear factor-κB (NF-κB) in the kidneys of old rats. Our results suggest that MHY3200 ameliorates age-associated renal inflammation by regulating NF-κB and FoxO1 via ROS/Akt signaling.
Keywords: aging; MHY3200; ROS; Akt; NF-κB; inflammation aging; MHY3200; ROS; Akt; NF-κB; inflammation

Share and Cite

MDPI and ACS Style

Kim, M.J.; Kim, D.H.; Bang, E.; Noh, S.G.; Chun, P.; Yokozawa, T.; Moon, H.R.; Chung, H.Y. PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules 2021, 26, 3197. https://doi.org/10.3390/molecules26113197

AMA Style

Kim MJ, Kim DH, Bang E, Noh SG, Chun P, Yokozawa T, Moon HR, Chung HY. PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules. 2021; 26(11):3197. https://doi.org/10.3390/molecules26113197

Chicago/Turabian Style

Kim, Min Jo, Dae Hyun Kim, EunJin Bang, Sang Gyun Noh, Pusoon Chun, Takako Yokozawa, Hyung Ryong Moon, and Hae Young Chung. 2021. "PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling" Molecules 26, no. 11: 3197. https://doi.org/10.3390/molecules26113197

APA Style

Kim, M. J., Kim, D. H., Bang, E., Noh, S. G., Chun, P., Yokozawa, T., Moon, H. R., & Chung, H. Y. (2021). PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling. Molecules, 26(11), 3197. https://doi.org/10.3390/molecules26113197

Article Metrics

Back to TopTop